journal article·2011-10

Comprehensive studies on the interactions between chitosan nanoparticles and some live cells

Ai-ping Zheng, Hui-xue Liu, Lan Yuan, Meng Meng, Jian-cheng Wang, Xuan Zhang, Qiang Zhang

Journal of Nanoparticle Research· Volume 13· Issue 10
Publisher page

Abstract

As more and more oral formulations of nanoparticles are used in clinical contexts, a comprehensive study on the mechanisms of interaction between polymer nanoparticles and live cells seems merited. Such a study was conducted and the results were compared to the polymer itself in order to demonstrate different kinds of effects that are brought into the cell by polymer and its nanoparticles, especially the effects on the biomembrane. Several techniques, including surface plasmon resonance (SPR), Fourier transformed infrared spectroscopy (FTIR), Raman spectroscopy, fluorescence polarization spectroscopy (FP), flow cytometry (FCM) with quantitative analysis, and confocal images with antibody staining were employed toward this end. The cytotoxicity in vitro was also evaluated. Chitosan (CS), a polycationic polymer, was used to prepare the nanoparticles. We demonstrate that chitosan nanoparticles (CS-NP) induce strong alterations in the distribution of membrane proteins, fluidity of membrane lipids, and general membrane structure. Furthermore, the uptake of CS-NP into Caco-2 cells was found to have a similar mechanism to that of CS molecules, but the differences in degree were noted. These results indicate that positive charge and nanoscale size were the factors that most significantly affected the interactions between the nanoparticles of polycationic polymers and live cells. However, no difference in cytotoxicity toward the Caco-2 cells was found between CS and CS-NP. This supports the idea that CS-NP is an effective and safe carrier for oral drug delivery.
Source: openaire · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: Advanced Drug Delivery Systems · Lipid Membrane Structure and Behavior · Surfactants and Colloidal Systems

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (36)

Show source-provided references
1. Agnihotri SA, Mallikarjuna NN, Aminabhavi TM (2004) Recent advances on chitosan-based micro- and nanoparticles in drug delivery. J Control Res 100:5–2810.1016/j.jconrel.2004.08.010 ↗
2. Bernkop-Schnürch A, Kast CE, Guggi D (2003) Permeation enhancing polymers in oral delivery of hydrophilic macromolecules: thiomer/GSH systems. J Control Release 93:95–10310.1016/j.jconrel.2003.05.001 ↗
3. Bravo-Osuna I, Vauthier C, Chacun Hm, Ponchel G (2008) Specific permeability modulation of intestinal paracellular pathway by chitosan-poly(isobutylcyanoacrylate) core-shell nanoparticles. Eur J Pharma Biopharma 69:436–44410.1016/j.ejpb.2007.12.012 ↗
4. Calvo P, Remunan-Lopez C, Vila-Jato JL, Aloso MJ (1997) Novel hydrophilic chitosan–polyethylene oxide nanoparticles as protein carriers. J Appl Poly Sci 63:125–13210.1002/(SICI)1097-4628(19970103)63:1<125::AID-APP13>3.0.CO;2-4 ↗
5. Carreno-Gomez B, Duncan R (1997) Evaluation of the biological properties of soluble chitosan and chitosan microspheres. Int J Pharm 148:231–24010.1016/S0378-5173(96)04847-8 ↗
6. Des Rieux A, Fievez V, Momtaz M, Detrembleur C, Alonso-Sande M, Van Gelder J, Cauvin A, Schneider YJ, Préat V (2007) Helodermin-loaded nanoparticles: characterization and transport across an in vitro model of the follicle-associated epithelium. J Control Rel 118:294–30210.1016/j.jconrel.2006.12.023 ↗
7. Dobrovolskaia MA, Aggarwal P, Hall JB, McNeil SE (2008) Preclinical studies to understand nanoparticle interaction with the immune system and its potential effects on nanoparticle biodistribution. Mol Pharm 5:487–49510.1021/mp800032f ↗
8. Dodane V, Khan MA, Merwin JR (1999) Effect of chitosan on epithelial permeability and structure. Int J Pharm 182:21–3210.1016/S0378-5173(99)00030-7 ↗
9. Fischer D, Li Y, Ahlemeyer B, Krieglstein J, Kissel T (2003) In vitro cytotoxicity testing of polycations: influence of polymer structure on cell viability and hemolysis. Biomaterials 24:1121–113110.1016/S0142-9612(02)00445-3 ↗
10. Florence AT, Hussain N (2001) Transcytosis of nanoparticle and dendrimer delivery systems: evolving vistas. Adv Drug Deli Rev 50:S69–S8910.1016/S0169-409X(01)00184-3 ↗
11. Gomez-Orellana I (2005) Strategies to improve oral drug bioavailability. Exper Opin Drug Deliv 2:419–43310.1517/17425247.2.3.419 ↗
12. Huang M, Ma ZS, Khor E, Lim LY (2002) Uptake of FITC-chitosan nanoparticles by A549 cells. Pharm Res 19:1488–149410.1023/A:1020404615898 ↗
13. Huang M, Khor E, Lim LY (2004) Uptake and cytotoxicity of chitosan molecules and nanoparticles: effects of molecular weight and degree of deacetylation. Pharm Res 21:344–35310.1023/B:PHAM.0000016249.52831.a5 ↗
14. Karlsson R (2004) SPR for molecular interaction analysis: a review of emerging application areas. J Mol Recognit 17:151–16110.1002/jmr.660 ↗
15. Kesisogloua F, Panmai S, Wu YH (2007) Nanosizing—Oral formulation development and biopharmaceutical evaluation. Adv Drug Deliv Rev 59:631–64410.1016/j.addr.2007.05.003 ↗
16. Kleinert HD, Rosenberg SH, Baker WR, Stein HH, Klinghofer V, Barlow J, Spina K, Polakowski J, Kovar P, Cohen J (1992) Discovery of a peptide-based rennin inhibitor with oral bioavailability and efficacy. Science 257:1940–194310.1126/science.1411510 ↗
17. Kneipp K, Kneipp H, Itzkan I, Dasari RR, Feld MS (1999) Ultrasensitive chemical analysis by Raman spectroscopy. Chem Rev 99:2957–297610.1021/cr980133r ↗
18. Kneipp K, Kneipp H, Corio P, Brown SD, Shafer K, Motz J, Perelman LT, Hanlon EB, Marucci A, Dresselhaus G, Dresselhaus MS (2000) Surface-enhanced and normal stokes and anti-stokes Raman spectroscopy of single-walled carbon nanotubes. Phys Rev Lett 84:3470–347310.1103/PhysRevLett.84.3470 ↗
19. Kneipp K, Kneipp H, Kneipp J (2006) Surface-enhanced Raman scattering in local optical fields of silver and gold nanoaggregates-from single-molecule Raman spectroscopy to ultrasensitive probing in live cells. Acc Chem Res 39:443–45010.1021/ar050107x ↗
20. Konsoula R, Barile FA (2005) Correlation of in vitro cytotoxicity with paracellular permeability in Caco-2 cells. Toxicol In Vitro 19:675–68410.1016/j.tiv.2005.03.006 ↗
21. Kristjánsdóttir K, Rudolph J (2003) A fluorescence polarization assay for native protein substrates of kinases. Anal Biochem 316:41–4910.1016/S0003-2697(03)00033-2 ↗
22. Lord RC, Yu NT (1970) Laser-excited Raman spectroscopy of biomolecules: I. Native lysozyme and its constituent amino acids. J Mol Biol 50:509–52410.1016/0022-2836(70)90208-1 ↗
23. Ma ZS, Lim LY (2003) Uptake and cytotoxicity of chitosan molecules and nanoparticles: effects of molecular weight and degree of deacetylation. Pharm Res 20:1812–181910.1023/B:PHAM.0000003379.76417.3e ↗
24. Mao HQ, Roy K, Troung-Le VL, Janes KA, Lin KY, Wang Y, August JT, Leong KW (2001) Chitosan-DNA nanoparticles as gene carriers: synthesis, characterization and transfection efficiency. J Control Res 70:399–42110.1016/S0168-3659(00)00361-8 ↗
25. Müller RH, Jacobs C, Kayser O (2001) Nanosuspensions as particulate drug formulations in therapy: rationale for development and what we can expect for the future. Adv Drug Deliv Rev 47:3–1910.1016/S0169-409X(00)00118-6 ↗
26. Munishkina LA, Fink AL (2007) Fluorescence as a method to reveal structures and membrane-interactions of amyloidogenic proteins. Biochim Biophys Acta 1768:1862–188510.1016/j.bbamem.2007.03.015 ↗
27. Porter CJH, Trevaskis NL, Charman WNC (2007) Lipids and lipid-based formulations: optimizing the oral delivery of lipophilic drugs. Nature Rev Drug Disco 6:23110.1038/nrd2197 ↗
28. Prego C, Carcia M, Torre D, Alonso MJ (2005) Transmucosal macromolecular drug delivery. J Control Rel 101:151–16210.1016/j.jconrel.2004.07.030 ↗
29. Qaqish RB, Amiji MM (1999) Synthesis of a fluorescent chitosan derivative and its application for the study of chitosan-mucin interactions. Carbohydr Polym 38:99–10710.1016/S0144-8617(98)00109-X ↗
30. Qi LF, Xu ZR, Jiang X, Hu CH, Zou XF (2004) Preparation and antibacterial activity of chitosan nanoparticles. Carbohydr Res 339:2693–270010.1016/j.carres.2004.09.007 ↗
31. Richardson SCW, Kolbe HVJ, Duncan R (1999) Potential of low molecular mass chitosan as a DNA delivery system: biocompatibility, body distribution and ability to complex and protect DNA. Int J Pharm 178:231–24310.1016/S0378-5173(98)00378-0 ↗
32. Trapani A, Lopedota A, Franco M, Cioffi N, Ieva E, Garcia-Fuentes M, Alonso MJ (2010) A comparative study of chitosan and chitosan/cyclodextrin nanoparticles as potential carriers for the oral delivery of small peptides. Eur J Pharm Biopharm 75:26–3210.1016/j.ejpb.2010.01.010 ↗
33. Tsukita S, Furuse M, Itoh M (1999) Structural and signalling molecules come together at tight junctions. Curr Opin Cell Boil 11:628–63310.1016/S0955-0674(99)00016-2 ↗
34. Vasioukin V, Fuchs E (2001) Actin dynamics and cell–cell adhesion in epithelia. Curr Opin Cell Biol 13:76–8410.1016/S0955-0674(00)00177-0 ↗
35. Weissenböck A, Wirth M, Gabor F (2004) WGA-grafted PLGA-nanospheres: preparation and association with Caco-2 single cells. J Control Release 99:383–39210.1016/j.jconrel.2004.07.025 ↗
36. Yin L, Ding JY, He CB, Cui LM, Tang C, Yin CH (2009) Drug permeability and mucoadhesion properties of thiolated trimethyl chitosan nanoparticles in oral insulin delivery. Biomaterials 30:5691–570010.1016/j.biomaterials.2009.06.055 ↗